Cargando…
A territory‐wide study on the impact of COVID‐19 on diabetes‐related acute care
Diabetes is a risk factor for the severity of coronavirus disease 2019 (COVID‐19). Little is known how the COVID‐19 pandemic has disrupted diabetes‐related acute care. We compared hospitalization rates for severe hyperglycemia or hypoglycemia during the COVID‐19 outbreak in Hong Kong (study period:...
Autores principales: | Lui, David Tak Wai, Lee, Chi Ho, Chow, Wing Sun, Fong, Carol Ho Yi, Woo, Yu Cho, Lam, Karen Siu Ling, Tan, Kathryn Choon Beng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404850/ https://www.ncbi.nlm.nih.gov/pubmed/32779868 http://dx.doi.org/10.1111/jdi.13368 |
Ejemplares similares
-
One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021) -
Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus
por: Lee, Chi-Ho, et al.
Publicado: (2022) -
Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation
por: Chang, Johnny Yau-Cheung, et al.
Publicado: (2022) -
Effect of type 2 diabetes on the inducible degrader of LDL receptor
por: Lam, Sum, et al.
Publicado: (2023) -
Is metformin a miracle or a menace in COVID‐19 patients with type 2 diabetes?
por: Lui, David Tak Wai, et al.
Publicado: (2021)